Varian sells 4-T MR system for brain study
Varian announced that it is selling a very high field MR research system to McLean Hospital of Belmont, MA, the largest psychiatric teaching hospital for Harvard Medical School, for research into human brain function associated with drug abuse and
Varian announced that it is selling a very high field MR research system to McLean Hospital of Belmont, MA, the largest psychiatric teaching hospital for Harvard Medical School, for research into human brain function associated with drug abuse and psychiatric disorders.
Very high field (4-tesla) systems such as this one cost from $3 million to $4 million and are used only in research applications. In addition to its imaging capabilities, the Varian system can be used for in vivo nuclear MR spectroscopy, a technique for determining structural and functional relationships of chemical compounds in the brain.
Systems have also been ordered by the University of California, Berkeley; Emory University in Atlanta; and the National Institute for Environmental Studies in Tsukuba, Japan.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Study: Abbreviated Breast MRI Offers Equivalent Accuracy to mpMRI for Women with Dense Breasts
May 20th 2025Emerging research suggests that abbreviated breast MRI offers comparable sensitivity and specificity as multiparametric MRI in women with extremely dense breasts with a nearly 50 percent reduction in reading time for radiologists.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
